← FDA Drug Approvals (Drugs@FDA)

LABETALOL HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 1999-11-29

Drug application

FDA Application #

ANDA075524

Application type

Abbreviated New Drug Application (Generic)

Brand name

LABETALOL HYDROCHLORIDE

Generic name

Labetalol Hydrochloride

Active ingredients

LABETALOL HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

RISING

First approval

1999-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown